Nuclear Medicine and Biology
Volume 34, Issue 5 , Pages 523-530 , July 2007

Transport of free 211At and 125I− in thyroid epithelial cells: effects of anion channel blocker 4,4′-diisothiocyanostilbene-2,2′-disulfonic acid on apical efflux and cellular retention

  • Ulrika Lindencrona

      Affiliations

    • Department of Radiation Physics, Göteborg University, SE-413 45 Göteborg, Sweden
    • Corresponding Author InformationCorresponding author. Department of Radiation Physics, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden. Tel.: +46 31 3421829; fax: +46 31 822493.
    • ,
  • Eva Forssell-Aronsson

      Affiliations

    • Department of Radiation Physics, Göteborg University, SE-413 45 Göteborg, Sweden
    • ,
  • Mikael Nilsson

      Affiliations

    • Institute of Anatomy and Cell Biology, Sahlgrenska Academy at Göteborg University, SE-405 30 Göteborg, Sweden

Received 2 February 2007 ,Revised 15 March 2007 ,Accepted 27 March 2007.

References 

  1. Spitzweg C, Harrington KJ, Pinke LA, Vile RG, Morris JC. The sodium iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab. 2001;86:3327–3335
  2. Chung J. Sodium iodide symporter: Its role in nuclear medicine. J Nucl Med. 2002;43:1188–1200
  3. Dohán O, Carrasco N. Advances in Na+/I− symporter (NIS) research in the thyroid and beyond. Mol Cell Endocrinol. 2003;213:59–70
  4. Dadachova E, Carrasco N. The Na+/I− symporter (NIS): imaging and therapeutic applications. Semin Nucl Med. 2004;34:23–31
  5. Riesco-Eizaguirre G, Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol. 2006;155:495–512
  6. Shimura H, Haraguchi K, Miyazaki A, Endo T, Onaya T. Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I− symporter gene. Endocrinology. 1997;138:4493–4496
  7. Haberkorn U, Kinscherf R, Kissel M, Kübler W, Mahmut M, Sieger S, et al. Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose. Gene Ther. 2003;10:774–780
  8. Lindencrona U, Nilsson M, Forssell-Aronsson E. Comparison of 211At and 125I ion transport in porcine thyroid epithelial cells cultured in bicameral chamber. Nucl Med Biol. 2001;28:41–50
  9. Carlin S, Mairs RJ, Welsh P, Zalutsky MR. Sodium-iodide symporter (NIS)-mediated accumulation of [211At]astatide in NIS-transfected human cancer cells. Nucl Med Biol. 2002;29:729–739
  10. Carlin S, Akabani G, Zalutsky MR. In vitro cytotoxicity of 211At-astatide and 131I-iodide to glioma tumor cells expressing the sodium/iodide symporter. J Nucl Med. 2003;44:1827–1838
  11. Petrich T, Helmeke HJ, Meyer GJ, Knapp WH, Potter E. Establishment of radioactive astatine and iodine uptake in cancer cell line expressing the human sodium/iodide symporter. Eur J Nucl Med Mol Imaging. 2002;29:842–854
  12. Petrich T, Quintanilla-Martinez L, Korkmaz Z, Samson E, Helmeke HJ, Meyer GJ, et al. Effective cancer therapy with the α-particle emitter [211At]astatine in a mouse model of genetically modified sodium/iodide symporter-expressing tumors. Clin Cancer Res. 2006;12:1342–1348
  13. ICRU . Stopping powers and ranges for protons and alpha particles. ICRU Report 49. Bethesda (Md): International Commission on Radiation Units and Measurements; 1993;
  14. Nilsson M, Björkman U, Ekholm R, Ericson LE. Iodide transport in primary cultured thyroid follicle cells: evidence of a TSH-regulated channel mediating iodide efflux selectively across the apical domain of the plasma membrane. Eur J Cell Biol. 1990;52:270–281
  15. Scott DA, Wang R, Kreman TM, Sheffield VC, Karniski LP. The Pendred syndrome gene encodes a chloride–iodide transport protein. Nat Genet. 1999;21:440–443
  16. Bidart JM, Mian C, Lazar V, Russo D, Filetti S, Caillou B, et al. Expression of pendrin and the Pendred syndrome (PDS) gene in human thyroid tissues. J Clin Endocrinol Metab. 2000;85:2028–2033
  17. Yoshida A, Taniguchi S, Hisatome I, Royaux IE, Green ED, Kohn L, et al. Pendrin is an iodide-specific apical porter responsible for iodide efflux from thyroid cells. J Clin Endocrinol Metab. 2002;87:3356–3361
  18. Gillam MP, Sidhaye AR, Lee EJ, Rutishauser J, Stephan CW, Kopp P. Functional characterization of pendrin in a polarized cell system. Evidence for pendrin-mediated apical iodide efflux. J Biol Chem. 2004;279:13004–13010
  19. Rodriguez AM, Perron B, Lacroix L, Caillou B, LeBlanc G, Schlumberger M, et al. Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. J Clin Endocrinol Metab. 2002;87:3500–3503
  20. Lacroix L, Pourcher T, Magnon C, Bellon N, Talbot M, Intaraphairot T, et al. Expression of the apical iodide transporter in human thyroid tissues: a comparison study with other iodide transporters. J Clin Endocrinol Metab. 2004;89:1423–1428
  21. Amphoux-Fazekas T, Samih N, Hovsépian S, Aouani A, Beauwens R, Fayet G. DIDS (4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid) increases iodide trapping, inhibits thyroperoxidase and antagonizes the TSH-induced apical iodide efflux in porcine thyroid cells. Mol Cell Endocrinol. 1998;141:129–140
  22. Lindegren S, Bäck T, Jacobsson L, Karlsson B, Skarnemark G. Dry-distillation from irradiated bismuth targets: a time-saving procedure with high recovery yields. Appl Radiat Isot. 2001;55:157–160
  23. Nilsson M, Björkman U, Ekholm R, Ericson LE. Polarized efflux of iodide in porcine thyrocytes occurs via a cAMP-regulated iodide channel in the apical plasma membrane. Acta Endocrinol. 1992;126:67–74
  24. Nilsson M, Ericson LE. Effects of epidermal growth factor on basolateral iodide uptake and apical iodide permeability in filter-cultured thyroid epithelium. Endocrinology. 1994;135:1428–1436
  25. Cobb LM, Harrison A, Dudley NE, Carr TEF, Humphreys JA. Relative concentration of astatine-211 and iodine-125 by human fetal thyroid and carcinoma of the thyroid in nude mice. Radiother Oncol. 1989;13:203–209
  26. Brown I, Carpenter RN. α-Particle endoradiotherapy: experimental studies with 211At- and tumour-affinic 211At-biomolecules. Radiochim Acta. 1989;47:143–147
  27. Ericson LE, Nilsson M. Effects of insulin-like growth factor I on growth, epithelial barrier and iodide transport in polarized pig thyrocyte monolayers. Eur J Endocrinol. 1996;135:118–127
  28. Vasáros L, Berei K. General properties of astatine. In:  Kugler HK,  Keller C editor. Gmelin handbook of inorganic chemistry — astatine. 8th ed. Berlin: Springer-Verlag; 1985;p. 107–128
  29. Lindencrona U, Sillfors-Elverby L, Nilsson M, Forssell-Aronsson E. Adsorption and volatility of free 211At and 125I−. Appl Radiat Isot. 2005;62:395–403
  30. Kogai T, Endo T, Saito T, Miyazaki A, Kawaguchi A, Onaya T. Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology. 1997;138:2227–2232
  31. Kopp P. Pendred's syndrome: identification of the genetic defect a century after its recognition. Thyroid. 1999;9:65–69
  32. Fitz JG, Basavappa S, McGill J, Melhus O, Cohn JA. Regulation of membrane chloride currents in rat bile duct epithelial cells. J Clin Invest. 1993;91:319–328
  33. Devuyst O, Golstein PE, Sanches MV, Piontek K, Wilson PD, Guggino WB, et al. Expression of CFTR in human and bovine thyroid epithelium. Am J Physiol. 1997;272:C1299–C1308
  34. Elisei R, Vivaldi A, Ciampi R, Faviana P, Basolo F, Santini F, et al. Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid. J Clin Endocrinol Metab. 2006;91:2389–2395

PII: S0969-8051(07)00094-7

doi: 10.1016/j.nucmedbio.2007.03.012

Nuclear Medicine and Biology
Volume 34, Issue 5 , Pages 523-530 , July 2007

Article Tools

* Image Usage & Resolution